Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Personalized Cancer Vaccine”

127 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 127 results

Testing effectiveness (Phase 2)Looking for participantsNCT07002203
What this trial is testing

Personalized Neoantigen Peptide Vaccines for Solid Tumors

Who this might be right for
Solid TumorsAdvanced CancerRecurrent Cancer+2 more
Seqker Biosciences, Inc. 10
Early research (Phase 1)UnknownNCT04864379
What this trial is testing

Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Sir Run Run Shaw Hospital 30
Not applicableLooking for participantsNCT06751953
What this trial is testing

Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment

Who this might be right for
Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University 10
Very early researchEnrolling By InvitationNCT07285434
What this trial is testing

Clinical Study of the Therapeutic Effectiveness of In-silico-Designed, Machine Learning Inspired, and Quantum-molecularly Coupled Personalized Neoantigenic Vaccines Microlyvaq™ in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Squamous Lung Cancer With FGFR1 AmplificationNon-Squamous Non Small Cell Lung Cancer
Biogenea Pharmaceuticals Ltd. 90
Testing effectiveness (Phase 2)Active Not RecruitingNCT04397003
What this trial is testing

Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive-stage Small Cell Lung Cancer
Washington University School of Medicine 6
Not applicableLooking for participantsNCT06752057
What this trial is testing

Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment

Who this might be right for
Advanced NSCLC
The First Affiliated Hospital of Nanchang University 10
Early research (Phase 1)Ended earlyNCT03422094
What this trial is testing

Neoantigen-based Personalized Vaccine Combined With Immune Checkpoint Blockade Therapy in Patients With Newly Diagnosed, Unmethylated Glioblastoma

Who this might be right for
Glioblastoma
Washington University School of Medicine 3
Early research (Phase 1)Study completedNCT03552718
What this trial is testing

QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.

Who this might be right for
Colorectal CancerBreast CancerHead and Neck Squamous Cell Carcinoma+4 more
NantBioScience, Inc. 5
Very early researchStudy completedNCT03631043
What this trial is testing

Personalized Vaccine in Treating Patients With Smoldering Multiple Myeloma

Who this might be right for
Smoldering Plasma Cell Myeloma
M.D. Anderson Cancer Center 30
Very early researchNot Yet RecruitingNCT06735508
What this trial is testing

MRNA Neoantigen Vaccine in Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
Guangdong Provincial People's Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT06751901
What this trial is testing

Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After Second-line Treatment

Who this might be right for
Advanced NSCLC
The First Affiliated Hospital of Nanchang University 10
Testing effectiveness (Phase 2)Study completedNCT06614140
What this trial is testing

Personalized Neoantigen Cancer Vaccine for Patients With Solid Tumors

Who this might be right for
CancerSolid Tumor, Adult
Seqker Biosciences, Inc. 8
Early research (Phase 1)Looking for participantsNCT06529822
What this trial is testing

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Who this might be right for
Muscle-Invasive Bladder CarcinomaGastroesophageal AdenocarcinomaMelanoma+1 more
Washington University School of Medicine 64
Early research (Phase 1)Study completedNCT02035956
What this trial is testing

IVAC MUTANOME Phase I Clinical Trial

Who this might be right for
Melanoma
BioNTech RNA Pharmaceuticals GmbH 15
Early research (Phase 1)Active Not RecruitingNCT02287428
What this trial is testing

Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM

Who this might be right for
Glioblastoma
Dana-Farber Cancer Institute 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT03897881
What this trial is testing

An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)

Who this might be right for
Melanoma
ModernaTX, Inc. 267
Early research (Phase 1)Study completedNCT03568058
What this trial is testing

Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers

Who this might be right for
Advanced Cancer
Aaron Miller 25
Early research (Phase 1)UnknownNCT05235607
What this trial is testing

Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors

Who this might be right for
CarcinomaMelanomaBladder Cancer+1 more
Sichuan University 60
Early research (Phase 1)Looking for participantsNCT06026800
What this trial is testing

Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Combination With Standard First-line Treatment in Subjects With Advanced Digestive System Neoplasms

Who this might be right for
Digestive System Neoplasms
Sir Run Run Shaw Hospital 20
Early research (Phase 1)Not Yet RecruitingNCT07300475
What this trial is testing

Personalized Cancer Vaccine (PCV) Strategy in Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Washington University School of Medicine 30
Next Page